Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-23-001307
Filing Date
2023-03-01
Accepted
2023-03-01 16:30:56
Documents
99
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_022823.htm   iXBRL 6-K 14101
2 EXHIBIT 99.1 exh_991.htm   iXBRL EX-99.1 1039864
3 EXHIBIT 99.2 exh_992.htm EX-99.2 273511
9 GRAPHIC devprog.jpg GRAPHIC 84370
10 GRAPHIC pipe.jpg GRAPHIC 81056
  Complete submission text file 0001171843-23-001307.txt   6597315

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE ptgef-20221231.xsd EX-101.SCH 97131
5 XBRL CALCULATION FILE ptgef-20221231_cal.xml EX-101.CAL 67148
6 XBRL DEFINITION FILE ptgef-20221231_def.xml EX-101.DEF 194441
7 XBRL LABEL FILE ptgef-20221231_lab.xml EX-101.LAB 373830
8 XBRL PRESENTATION FILE ptgef-20221231_pre.xml EX-101.PRE 337627
93 EXTRACTED XBRL INSTANCE DOCUMENT f6k_022823_htm.xml XML 1088750
Mailing Address 6 ADELAIDE ST. EAST SUITE 300 TORONTO A6 M5C 1H6
Business Address 6 ADELAIDE ST. EAST SUITE 300 TORONTO A6 M5C 1H6 416-737-7600
PORTAGE BIOTECH INC. (Filer) CIK: 0001095435 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-40086 | Film No.: 23694069
SIC: 1311 Crude Petroleum & Natural Gas